Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jillian G Baker

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|April 26, 2013
Synthesis and in vitro and in vivo characterization of highly β1-selective β-adrenoceptor partial agonistsShailesh N Mistry, Jillian G Baker, Peter M Fischer, et al.
Chemical Communications (Cambridge, England)|September 22, 2021
Fragment evolution for GPCRs: the role of secondary binding sites in optimizationFlorent Chevillard, Ádám Kelemen, Jillian G Baker, et al.
Function (Oxford, England)|November 15, 2024
Pancreatic Ductal Adenocarcinoma, β-blockers, and Antihistamines: A Clinical Trial Is NeededJillian G Baker, Erica K Sloan, Kevin D G Pfleger, et al.
British Journal of Pharmacology|January 29, 2010
Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligandsJillian G Baker, Richard Middleton, Luke Adams, et al.
Journal of Medicinal Chemistry|August 30, 2011
Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptorsJillian G Baker, Luke A Adams, Karolina Salchow, et al.
Chemical Biology & Drug Design|August 29, 2018
Pharmacological and SAR analysis of the LINS01 compounds at the human histamine H<sub>1</sub> , H<sub>2</sub> , and H<sub>3</sub> receptorsMichelle Fidelis Corrêa, Álefe Jhonatas Ramos Barbosa, Gustavo Ariel Borges Fernandes, et al.
ACS Pharmacology & Translational Science|August 25, 2020
Using Esterase Selectivity to Determine the <i>In Vivo</i> Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-BlockersJillian G Baker, Christophe Fromont, Marjorie Bruder, et al.
Nature|January 14, 2011
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptorTony Warne, Rouslan Moukhametzianov, Jillian G Baker, et al.
Journal of Medicinal Chemistry|January 26, 2007
New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cellsRichard J Middleton, Stephen J Briddon, Yolande Cordeaux, et al.
Nature|July 3, 2008
Structure of a beta1-adrenergic G-protein-coupled receptorTony Warne, Maria J Serrano-Vega, Jillian G Baker, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|April 26, 2013
Synthesis and in vitro and in vivo characterization of highly β1-selective β-adrenoceptor partial agonistsShailesh N Mistry, Jillian G Baker, Peter M Fischer, et al.
Chemical Communications (Cambridge, England)|September 22, 2021
Fragment evolution for GPCRs: the role of secondary binding sites in optimizationFlorent Chevillard, Ádám Kelemen, Jillian G Baker, et al.
Function (Oxford, England)|November 15, 2024
Pancreatic Ductal Adenocarcinoma, β-blockers, and Antihistamines: A Clinical Trial Is NeededJillian G Baker, Erica K Sloan, Kevin D G Pfleger, et al.
British Journal of Pharmacology|January 29, 2010
Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligandsJillian G Baker, Richard Middleton, Luke Adams, et al.
Journal of Medicinal Chemistry|August 30, 2011
Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptorsJillian G Baker, Luke A Adams, Karolina Salchow, et al.
Chemical Biology & Drug Design|August 29, 2018
Pharmacological and SAR analysis of the LINS01 compounds at the human histamine H<sub>1</sub> , H<sub>2</sub> , and H<sub>3</sub> receptorsMichelle Fidelis Corrêa, Álefe Jhonatas Ramos Barbosa, Gustavo Ariel Borges Fernandes, et al.
ACS Pharmacology & Translational Science|August 25, 2020
Using Esterase Selectivity to Determine the <i>In Vivo</i> Duration of Systemic Availability and Abolish Systemic Side Effects of Topical β-BlockersJillian G Baker, Christophe Fromont, Marjorie Bruder, et al.
Nature|January 14, 2011
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptorTony Warne, Rouslan Moukhametzianov, Jillian G Baker, et al.
Journal of Medicinal Chemistry|January 26, 2007
New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cellsRichard J Middleton, Stephen J Briddon, Yolande Cordeaux, et al.
Nature|July 3, 2008
Structure of a beta1-adrenergic G-protein-coupled receptorTony Warne, Maria J Serrano-Vega, Jillian G Baker, et al.
Pageof 6